Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections.

Victoria GavaghanJessica L MillerJennifer Dela-Pena

Published in: Infection (2022)

Our results provide additional insight into the in vivo activity of cefiderocol. Cefiderocol remains a salvage option for carbapenem-resistant Gram-negative organisms.

Keyphrases

gram negative
multidrug resistant
stem cells
replacement therapy
chemotherapy induced